PLx Pharma Inc expected to post a loss of 21  cents a share - Earnings Preview

PLx Pharma Winddown

12/05/2021 13:42

* PLx Pharma Inc  PLXP.OQ   PLXP.O  is expected to show a fall
in quarterly revenue when it reports results on May 14 .
​* Refinitiv's mean analyst estimate for PLx Pharma Inc is for a
loss of 21 cents per share. For the same quarter last year, the
company reported earnings of 8 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for PLx Pharma Inc
is $16​, about 39.3% above​ its last closing price of $9.71. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  -0.29       -0.29      -0.87     Missed  -200
 Sep. 30 2020  -0.42       -0.42      -0.40     Beat    5.9
 Jun. 30 2020  -0.41       -0.41      -0.66     Missed  -59​
 Mar. 31 2020  -0.40       -0.39      0.08      Beat    120.3
 Dec.          ​           -0.48      -0.25     Beat    47.9​
 31​ 2019​                                              
 Sep. 30 2019  -0.50       -0.49      0.09      Beat    118.2​
 Jun. 30 2019  -0.43       -0.43      -1.10     Missed  -152.9
 Mar. 31 2019  -0.29       -0.33      -1.24     Missed  -275.8
 This summary was machine generated May 12 at 12:42 GMT.  All
figures in US dollars unless otherwise stated